RxDoctor Payments Data

Hieu Tieu

Family · Boston, MANPI 1942676259

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 69.9% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $2,276, more than ten times the $203 reported in 2021. Among family clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,396in general payments, 2019–2025

Across 52 payments — averaging $84.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Abbott$418
  • Biosense Webster, Inc.$281
  • Itamar Medical Inc$171
  • ZOLL Respicardia, Inc.$163
  • Biotronik Inc.$153
  • plus $137 from 1 others

What the payments were for

  • Consulting fees$95022%
  • Travel & lodging$1,16126%
  • Food & beverage$2,21950%
  • Entertainment$662%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,396 in reported general payments places this provider in the 95th percentile of 2,320 family providers in Massachusetts.

See all family providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$27,662
Medicare patients
191
Services billed
292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban150$159,621
XareltoRivaroxaban28$39,967
Metoprolol Succinate96$1,493
Flecainide Acetate12$593
Amiodarone Hcl20$348
ClopidogrelClopidogrel Bisulfate22$299
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$255
Pantoprazole Sodium14$131

Paid to pharmacies, not to this prescriber.

Other family in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →